Notes from the Field: Respiratory Symptoms and Skin Irritation Among Hospital Workers Using a New Disinfection Product - Pennsylvania, 2015

In March 2014, a new disinfection product, consisting of hydrogen peroxide, peroxyacetic acid, and acetic acid, was introduced at a Pennsylvania hospital to aid in the control of health care-associated infections. The product is an Environmental Protection Agency-registered non-bleach sporicide adve...

Full description

Saved in:
Bibliographic Details
Published in:MMWR. Morbidity and mortality weekly report 2016-04, Vol.65 (15), p.400-401
Main Authors: Hawley, Brie, Casey, Megan L, Cox-Ganser, Jean M, Edwards, Nicole, Fedan, Kathleen B, Cummings, Kristin J
Format: Article
Language:English
Subjects:
Asthma - chemically induced
Disinfectants - adverse effects
Humans
Occupational Diseases - chemically induced
Occupational Diseases - epidemiology
Pennsylvania - epidemiology
Personnel, Hospital
Prevalence
Respiratory Tract Diseases - chemically induced
Respiratory Tract Diseases - epidemiology
Skin Diseases - chemically induced
Skin Diseases - epidemiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In March 2014, a new disinfection product, consisting of hydrogen peroxide, peroxyacetic acid, and acetic acid, was introduced at a Pennsylvania hospital to aid in the control of health care-associated infections. The product is an Environmental Protection Agency-registered non-bleach sporicide advertised as a one-step cleaner, disinfectant, and deodorizer. According to the manufacturer's safety data sheet, the product requires no personal protective equipment when it is diluted with water by an automated dispenser before use. On January 30, 2015, CDC's National Institute for Occupational Health (NIOSH) received a confidential employee request to conduct a health hazard evaluation at the hospital. The request cited concerns about exposure of hospital environmental services staff members to the product and reported symptoms among persons who had used the product that included eye and nasal problems, asthma-like symptoms, shortness of breath, skin problems, wheeze, chest tightness, and cough.
ISSN:0149-2195
1545-861X
DOI:10.15585/mmwr.mm6515a3